Annual Cash & Cash Equivalents
$12.21 M
+$2.61 M+27.20%
December 31, 2022
Summary
- As of February 10, 2025, HTGM annual cash & cash equivalents is $12.21 million, with the most recent change of +$2.61 million (+27.20%) on December 31, 2022.
- During the last 3 years, HTGM annual cash & cash equivalents has risen by +$4.59 million (+60.25%).
Performance
HTGM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.00 M
-$9.21 M-75.46%
March 31, 2023
Summary
- As of February 10, 2025, HTGM quarterly cash and cash equivalents is $3.00 million, with the most recent change of -$9.21 million (-75.46%) on March 31, 2023.
- Over the past year, HTGM quarterly cash and cash equivalents has dropped by -$11.62 million (-79.50%).
Performance
HTGM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HTGM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.2% | -79.5% |
| 3 y3 years | +60.3% | -71.2% |
| 5 y5 years | +22.5% | -85.4% |
HTGM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -21.4% | -79.5% | at low |
| 5 y | 5-year | -45.5% | -37.6% | -86.6% | at low |
| alltime | all time | -45.5% | -85.1% | -91.4% | -47.8% |
HTG Molecular Diagnostics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $3.00 M(-75.5%) |
| Dec 2022 | $12.21 M(+27.2%) | $12.21 M(+280.1%) |
| Sep 2022 | - | $3.21 M(-44.2%) |
| Jun 2022 | - | $5.76 M(-60.6%) |
| Mar 2022 | - | $14.61 M(+52.2%) |
| Dec 2021 | $9.60 M(-57.1%) | $9.60 M(-6.2%) |
| Sep 2021 | - | $10.23 M(-24.7%) |
| Jun 2021 | - | $13.58 M(-37.7%) |
| Mar 2021 | - | $21.78 M(-2.8%) |
| Dec 2020 | $22.40 M(+193.9%) | $22.40 M(+18.6%) |
| Sep 2020 | - | $18.88 M(-10.1%) |
| Jun 2020 | - | $21.01 M(+102.0%) |
| Mar 2020 | - | $10.40 M(+36.5%) |
| Dec 2019 | $7.62 M(-9.6%) | $7.62 M(-78.1%) |
| Sep 2019 | - | $34.85 M(+195.0%) |
| Jun 2019 | - | $11.81 M(+69.4%) |
| Mar 2019 | - | $6.98 M(-17.3%) |
| Dec 2018 | $8.43 M | $8.43 M(+36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $6.16 M(+6.7%) |
| Jun 2018 | - | $5.77 M(-71.9%) |
| Mar 2018 | - | $20.53 M(+106.0%) |
| Dec 2017 | $9.97 M(+32.8%) | $9.97 M(+10.2%) |
| Sep 2017 | - | $9.05 M(-32.5%) |
| Jun 2017 | - | $13.40 M(+384.1%) |
| Mar 2017 | - | $2.77 M(-63.1%) |
| Dec 2016 | $7.51 M(+127.9%) | $7.51 M(+35.9%) |
| Sep 2016 | - | $5.52 M(-26.5%) |
| Jun 2016 | - | $7.51 M(+52.6%) |
| Mar 2016 | - | $4.92 M(+49.4%) |
| Dec 2015 | $3.29 M(-8.8%) | $3.29 M(+26.8%) |
| Sep 2015 | - | $2.60 M(-76.7%) |
| Jun 2015 | - | $11.17 M(+614.2%) |
| Mar 2015 | - | $1.56 M(-56.7%) |
| Dec 2014 | $3.61 M(+99.1%) | $3.61 M(-53.0%) |
| Sep 2014 | - | $7.69 M(+323.9%) |
| Dec 2013 | $1.82 M(-75.2%) | $1.82 M |
| Dec 2012 | $7.32 M | - |
FAQ
- What is HTG Molecular Diagnostics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics annual cash & cash equivalents year-on-year change?
- What is HTG Molecular Diagnostics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics quarterly cash and cash equivalents year-on-year change?
What is HTG Molecular Diagnostics annual cash & cash equivalents?
The current annual cash & cash equivalents of HTGM is $12.21 M
What is the all time high annual cash & cash equivalents for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high annual cash & cash equivalents is $22.40 M
What is HTG Molecular Diagnostics annual cash & cash equivalents year-on-year change?
Over the past year, HTGM annual cash & cash equivalents has changed by +$2.61 M (+27.20%)
What is HTG Molecular Diagnostics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HTGM is $3.00 M
What is the all time high quarterly cash and cash equivalents for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high quarterly cash and cash equivalents is $34.85 M
What is HTG Molecular Diagnostics quarterly cash and cash equivalents year-on-year change?
Over the past year, HTGM quarterly cash and cash equivalents has changed by -$11.62 M (-79.50%)